For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Latest independent drug information about the Apidra brand of medicine and treatments, written and reviewed by experts in Australia.
Insulin glulisine is the active ingredient in the medicine brand Apidra.
| Filter by audience: | |
|---|---|
| All | |
| Consumer | |
| Health professional | |
| Researchers & evaluators | |
| Members & stakeholders | |
| Other | |
| Title | Description | Type | Audience ![]() |
Date* |
|---|---|---|---|---|
| Insulin - Independent medicine & health information | Insulin is commonly prescribed for type 1, type 2 and gestational diabetes. It’s a hormone produced by the pancreas & is used to control blood sugar (glucose) levels. Read more about the benefits & side effects of insulin. | Web page | Consumers,Others,Research & Evaluation community | 2011-11-14 00:00:00 |
| Types & forms of insulin available in Australia - Independent medicine & health information | Insulin is available in several different types & forms to treat diabetes. View our list of the types of insulin available in Australia. | Web page | Consumers,Others,Research & Evaluation community | 2011-11-14 00:00:00 |
| Types & forms of insulin available in Australia - Independent medicine & health information | Insulin is available in several different types and forms to treat diabetes.View our list of the types of insulin available in Australia. | Web page | Consumers,Others,Research & Evaluation community | 2011-12-06 00:00:00 |
| Insulin - Independent medicine & health information | Insulin is commonly prescribed for type 1, type 2 and gestational diabetes. It’s an artificial version of the hormone produced by the pancreas & is used to control blood sugar (glucose) levels in place of your body's natural insulin. Read more about the benefits & side effects of insulin. | Web page | Consumers,Others,Research & Evaluation community | 2011-12-06 00:00:00 |
| Another ultra-short-acting insulin PBS listed: insulin glulisine | Insulin glulisine (Apidra) is the third ultra-short-acting insulin analogue listed on the PBS, the others being insulin lispro and insulin aspart, for treatment of type 1 and type 2 diabetes. | Professional publication - NPS RADAR - Brief item | Health Professionals | 2007-12-01 00:00:00 |
| Apidra | Consumer information from the manufacturer about the use of Apidra (insulin glulisine). | Consumer publication - Consumer medicine information leaflet (CMI) | Consumers | 2010-08-26 00:00:00 |
Most medicines have two names: the active ingredient name and the brand name. It’s important to be able to identify each of your medicines by the active ingredient as well as the brand name. Knowing the active ingredient name will help you avoid confusing your medicines.
There may be several brands that contain the same active ingredient. There may also be brands that contain multiple active ingredients. NPS aims to help people find information about their medicines easily, so brand information may be included, but not all brands may be listed. Reference to a brand does not mean NPS recommends one brand over another. If you are not sure about your medicine’s active ingredient(s), check the Medicines Name Finder, or ask your doctor or pharmacist.
Below is information on medicines that contain the active ingredient insulin glulisine.
| Title | Description | Type | Audience ![]() |
Date* |
|---|---|---|---|---|
| Types & forms of insulin available in Australia - Independent medicine & health information | Insulin is available in several different types & forms to treat diabetes. View our list of the types of insulin available in Australia. | Web page | Consumers,Others,Research & Evaluation community | 2011-11-14 00:00:00 |
| Types & forms of insulin available in Australia - Independent medicine & health information | Insulin is available in several different types and forms to treat diabetes.View our list of the types of insulin available in Australia. | Web page | Consumers,Others,Research & Evaluation community | 2011-12-06 00:00:00 |
| Another ultra-short-acting insulin PBS listed: insulin glulisine | Insulin glulisine (Apidra) is the third ultra-short-acting insulin analogue listed on the PBS, the others being insulin lispro and insulin aspart, for treatment of type 1 and type 2 diabetes. | Professional publication - NPS RADAR - Brief item | Health Professionals | 2007-12-01 00:00:00 |
| Apidra | Consumer information from the manufacturer about the use of Apidra (insulin glulisine). | Consumer publication - Consumer medicine information leaflet (CMI) | Consumers | 2010-08-26 00:00:00 |
Information on this website is published by NPS — an independent, evidence based, not-for-profit organisation funded by the Australian Government Department of Health and Ageing.
NPS develops its information under the guidance of experts in their field, editorial panels, expert reviewers and consumers. Find out more about how we develop our content.
Date published: 2010-12-17 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.